Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1B | P47901 | 19/20 | 0.63 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4308725 | 0.91 | AVPR1B (0.75) | AVPR1B | |
| SCHEMBL4302713 | 0.86 | AVPR1B (0.44) | AVPR1B | |
| SCHEMBL4318238 | 0.82 | AVPR1B (0.40) | AVPR1B | |
| SCHEMBL4315024 | 0.80 | AVPR1B (0.84) | AVPR1B | |
| SCHEMBL8013549 | 0.77 | AVPR1B (0.56) | AVPR1B | |
| SCHEMBL4302783 | 0.77 | AVPR1B (1.00) | AVPR1B | |
| SCHEMBL4306495 | 0.76 | AVPR1B (0.74) | AVPR1B | |
| SCHEMBL4302745 | 0.73 | AVPR1B (0.81) | AVPR1B | |
| SCHEMBL4309843 | 0.73 | AVPR1B (0.52) | AVPR1B | |
| SCHEMBL4308522 | 0.71 | AVPR1B (1.00) | AVPR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009130231-A1 | PYRROLO [1, 2-A] PYRAZINE DERIVATIVES AS VASOPRESSIN VIB RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2009-10-29 | — | — | WO | claimed |
| WO-2009130231-A1 | PYRROLO [1, 2-A] PYRAZINE DERIVATIVES AS VASOPRESSIN VIB RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2009-10-29 | — | — | WO | disclosed |
| WO-2009130231-A1 | PYRROLO [1, 2-A] PYRAZINE DERIVATIVES AS VASOPRESSIN VIB RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2009-10-29 | — | — | WO | disclosed |